Momentus Inc. (NASDAQ:MNTS – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 1,400,000 shares, a decrease of 24.7% from the October 15th total of 1,860,000 shares. Approximately 5.9% of the company’s stock are short sold. Based on an average trading volume of 15,480,000 shares, the short-interest ratio is currently 0.1 days.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Momentus stock. Virtu Financial LLC lifted its position in shares of Momentus Inc. (NASDAQ:MNTS – Free Report) by 142.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 78,955 shares of the company’s stock after acquiring an additional 46,392 shares during the period. Virtu Financial LLC owned about 0.66% of Momentus worth $34,000 at the end of the most recent reporting period. 9.24% of the stock is owned by institutional investors and hedge funds.
Momentus Trading Up 1.1 %
NASDAQ MNTS traded up $0.01 during trading hours on Friday, reaching $0.63. 1,855,881 shares of the company traded hands, compared to its average volume of 2,450,546. Momentus has a 12 month low of $0.35 and a 12 month high of $3.32. The company has a 50 day moving average of $0.56 and a two-hundred day moving average of $0.58.
Momentus Company Profile
Momentus Inc, together with its subsidiaries, operates as a commercial space company. The company focuses on providing in-space infrastructure services, including in-space transportation, hosted payloads, and in-orbit services. Its principal and target customers include satellite operators. The company is headquartered in San Jose, California.
See Also
- Five stocks we like better than Momentus
- 3 Warren Buffett Stocks to Buy Now
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What is a SEC Filing?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Canada Bond Market Holiday: How to Invest and Trade
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Momentus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Momentus and related companies with MarketBeat.com's FREE daily email newsletter.